Cargando…

The intravenous and oral pharmacokinetics of lotilaner in dogs

BACKGROUND: Lotilaner is a new oral ectoparasiticide from the isoxazoline class developed for the treatment of flea and tick infestations in dogs. It is formulated as pure S-enantiomer in flavoured chewable tablets (Credelio™). The pharmacokinetics of lotilaner were thoroughly determined after intra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toutain, Céline E., Seewald, Wolfgang, Jung, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664907/ https://www.ncbi.nlm.nih.gov/pubmed/29089051 http://dx.doi.org/10.1186/s13071-017-2475-z

Ejemplares similares

Pharmacokinetics of lotilaner following a single oral or intravenous administration in cats
por: Toutain, Céline E., et al.
Publicado: (2018)

Assessment of the onset of lotilaner (Credelio™) speed of kill of fleas on dogs
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Assessment of the speed of flea kill of lotilaner (Credelio™) throughout the month following oral administration to dogs
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Laboratory evaluation of the speed of kill of lotilaner (Credelio™) against Ixodes ricinus ticks on dogs
por: Murphy, Martin, et al.
Publicado: (2017)

Laboratory evaluation of the efficacy of lotilaner (Credelio™) against Haemaphysalis longicornis infestations of dogs
por: Otaki, Hiroshi, et al.
Publicado: (2018)

Laboratory evaluations of the 3-month efficacy of oral lotilaner (Credelio™) against experimental infestations of dogs with the Australian paralysis tick, Ixodes holocyclus
por: Baker, Kim, et al.
Publicado: (2018)

A randomized, controlled study to assess the efficacy and safety of lotilaner (Credelio™) in controlling ticks in client-owned dogs in Europe
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Two randomized, controlled studies to assess the efficacy and safety of lotilaner (Credelio™) in preventing Dermacentor reticulatus transmission of Babesia canis to dogs
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Laboratory evaluations of the immediate and sustained effectiveness of lotilaner (Credelio™) against three common species of ticks affecting dogs in Europe
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Laboratory evaluation of the efficacy and speed of kill of lotilaner (Credelio™) against Ctenocephalides felis on cats
por: Cavalleri, Daniela, et al.
Publicado: (2018)

A randomised, blinded, controlled field study to assess the efficacy and safety of lotilaner tablets (Credelio™) in controlling fleas in client-owned dogs in European countries
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Laboratory evaluations of the immediate and sustained efficacy of lotilaner (Credelio™) against four common species of ticks affecting dogs in North America
por: Murphy, Martin, et al.
Publicado: (2017)

Laboratory evaluation of the efficacy and speed of kill of lotilaner (Credelio(TM)) against Ixodes ricinus ticks on cats
por: Cavalleri, Daniela, et al.
Publicado: (2018)

A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio™) in controlling fleas in client-owned cats in Europe
por: Cavalleri, Daniela, et al.
Publicado: (2018)

A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio™) in controlling ticks in client-owned cats in Europe
por: Cavalleri, Daniela, et al.
Publicado: (2018)

Safety evaluation of lotilaner in dogs after oral administration as flavoured chewable tablets (Credelio™)
por: Kuntz, Emmanuelle A., et al.
Publicado: (2017)

Clinical, Parasitological, and Serological Follow-Up of Dogs with Sarcoptic Mange Treated Orally with Lotilaner
por: Moog, F., et al.
Publicado: (2021)

Lotilaner - a novel systemic tick and flea control product for dogs
por: Little, Susan E.
Publicado: (2017)

A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™ CAT) in eliminating fleas in client-owned cats in the USA
por: Chappell, Kimberly, et al.
Publicado: (2021)

Efficacy of lotilaner (Credelio™) against the adult cat flea, Ctenocephalides felis and flea eggs following oral administration to dogs
por: Young, Lisa, et al.
Publicado: (2020)

Laboratory evaluation of the efficacy of lotilaner (Credelio™) against Amblyomma cajennense (sensu lato) infestations of dogs
por: Lasmar, Pedro Veloso Facury, et al.
Publicado: (2018)

Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration
por: Kilp, Susanne, et al.
Publicado: (2014)

Efficacy of lotilaner (Credelio™), a novel oral isoxazoline against naturally occurring mange mite infestations in dogs caused by Demodex spp.
por: Snyder, Daniel E., et al.
Publicado: (2017)

Pharmacokinetics of esomeprazole following intravenous and oral administration in healthy dogs
por: Cook, Emily K, et al.
Publicado: (2016)

Efficacy of lotilaner against myiasis caused by Cochliomyia hominivorax (Diptera: Calliphoridae) in naturally infested dogs
por: do Vale, Tássia Lopes, et al.
Publicado: (2023)

Early onset of pre-lethal effects of lotilaner (Credelio(®)) on Amblyomma americanum ticks on experimentally infested dogs
por: Wenger, Martha J., et al.
Publicado: (2021)

Population Pharmacokinetics of Intravenous Amoxicillin Combined With Clavulanic Acid in Healthy and Critically Ill Dogs
por: Vegas Cómitre, Maria D., et al.
Publicado: (2021)

Safety of lotilaner flavoured chewable tablets (Credelio(TM)) after oral administration in cats
por: Kuntz, Emmanuelle A., et al.
Publicado: (2018)

Pharmacokinetics of intravenous, oral transmucosal, and intranasal buprenorphine in healthy male dogs
por: Enomoto, Hiroko, et al.
Publicado: (2022)

Long-term and acute safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio(®) Plus) in juvenile and adult dogs
por: Riggs, Kari L., et al.
Publicado: (2021)

Lotilaner Ophthalmic Solution 0.25%: First Approval
por: Syed, Yahiya Y.
Publicado: (2023)

Six-month safety evaluation of robenacoxib tablets (Onsior™) in dogs after daily oral administrations
por: Toutain, Céline E., et al.
Publicado: (2018)

Intravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy
por: Vuu, Irene, et al.
Publicado: (2016)

In-home assessment of flea control and dermatologic lesions in dogs provided by lotilaner (Credelio(®)) and spinosad (Comfortis(®)) in west central Florida
por: Dryden, Michael W., et al.
Publicado: (2019)

Correction to: Lotilaner Ophthalmic Solution 0.25%: First Approval
por: Syed, Yahiya Y.
Publicado: (2023)

Pharmacokinetics and tolerability of lefamulin following intravenous and oral dosing
por: Wicha, Wolfgang W, et al.
Publicado: (2019)

A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA
por: Karadzovska, Daniela, et al.
Publicado: (2017)

The effect of food on the pharmacokinetics of oral fluralaner in dogs
por: Walther, Feli M, et al.
Publicado: (2014)

Pharmacokinetics of BMEDA after Intravenous Administration in Beagle Dogs
por: Chang, Chih-Hsien, et al.
Publicado: (2014)

Effectiveness of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio(®) Plus) for the treatment of larval and immature adult stages of Ancylostoma caninum in experimentally infected dogs
por: Snyder, Daniel E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sgciog4old60usajq1ug6sgb1n